Skip to main content

Find Clinical Trials

Home
Conditions
Intermediate Stage of Hepatocellular Carcinoma

Clinical trial condition

Intermediate Stage of Hepatocellular Carcinoma

Explore clinical trials studying Intermediate Stage of Hepatocellular Carcinoma. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Intermediate Stage of Hepatocellular Carcinoma trial results

Completed

CTLA-4 /PD-L1 Blockade Following Transarterial Chemoembolization (DEB-TACE) in Patients With Intermediate Stage of HCC (Hepatocellular Carcinoma) Using Durvalumab and Tremelimumab

NCT03638141

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +11 more
Locations: Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States

View Trial Details